Pharmaceutical Supply Chain Security Act
- Last Action
- 7/20/2023
Actions
- 2023-07-20Read twice and referred to the Committee on Foreign Relations.
- 2023-07-20Introduced in Senate
CRS Summary
As of 2023-07-20 (00)
Pharmaceutical Supply Chain Security Act
This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.
Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.
Cosponsors (1)
- Gary Peters (D-MI)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.